Ergomed plc Cancellation of admission to trading of shares (2856T)

TIDMERGO

RNS Number : 2856T

Ergomed plc

14 November 2023

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN WHOLE OR IN PART IN, INTO OR FROM ANY JURISDICTION WHERE TO DO SO WOULD CONSTITUTE A VIOLATION OF THE RELEVANT LAWS OR REGULATIONS OF THAT JURISDICTION.

For immediate release

14 November 2023

Ergomed plc

Cancellation of admission to trading of Ergomed Shares

Further to the announcement on 13 November 2023 that the Scheme for the acquisition of the entire issued and to be issued ordinary share capital of Ergomed plc ("Ergomed" or the "Company") by Eden AcquisitionCo Limited has now become Effective in accordance with its terms, Ergomed confirms that AIM has cancelled the admission to trading of Ergomed Shares on AIM with effect from 7.00 a.m. today, 14 November 2023.

Defined terms used but not defined in this announcement have the meanings set out in the Scheme Document dated 22 September 2023. All references to times in this announcement are to London time.

Enquiries:

Ergomed [phone]

Miroslav Reljanović (Executive Chairman)

Jonathan Curtain (Chief Financial Officer)

Keith Byrne (Senior Vice President, Capital Markets and Strategy)

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

MSCDZMMMVFZGFZM

(END) Dow Jones Newswires

November 14, 2023 02:30 ET (07:30 GMT)